Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic
This case series describes 20 children and adolescents who presented with new-onset acral inflammatory lesions during the COVID-19 pandemic.
This case series describes 20 children and adolescents who presented with new-onset acral inflammatory lesions during the COVID-19 pandemic.
This Viewpoint discusses the proliferation of Medicare Advantage plans targeting specific groups of individuals and whether these plans will improve quality of care for beneficiaries.
This essay describes the author’s experience with a patient that illustrates what undocumented individuals living in Florida are experiencing due to Bill 1718.
This cohort study evaluates whether door-to-treatment time is associated with outcome among patients with anticoagulation-associated intracerebral hemorrhage treated with reversal interventions.
This cohort study assesses the increase in second primary malignant neoplasms and T-cell malignant neoplasm cases associated with chimeric antigen receptor–T cells.
This quality improvement study investigates usage patterns of codes for inflammatory arthritides under International Statistical Classification of Diseases and Related Health Problems, Tenth Revision vs…
This case-control study of US military service members examines the sensitivity of 2 imaging techniques targeting white matter microstructure for diagnosis and prognosis of outcomes…
This multicenter diagnostic study determines the intermodality variability of left ventricular ejection fraction (LVEF) measured by echocardiography, gated single-photon emission computed tomography (SPECT), and cardiovascular…
This cohort study evaluates if neighborhood disadvantage is associated with shorter breast cancer–specific survival after controlling for individual, tumor, and treatment characteristics in a national…
This cross-sectional study investigates the frequency and intensity of somatic symptoms in children and adolescents who experienced traumatic events.
This report describes the development of an 18-gene urine panel for high-grade prostate cancer and validates its external performance relative to current guideline-endorsed biomarkers.